Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors (Q87550003)
Jump to navigation
Jump to search
scientific article published on 11 August 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors |
scientific article published on 11 August 2014 |
Statements
Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors (English)
Jeffrey R Infante
Anthony J Olszanski
Shyeilla V Dhuria
Suman Sen
Scott Cameron